Skip to main content
OpenTrials

Clinical trial condition

Chronic Obstructive Pulmonary Disease (COPD)

Explore clinical trials studying Chronic Obstructive Pulmonary Disease (COPD). Study availability and eligibility vary by location and protocol.

428 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Chronic Obstructive Pulmonary Disease (COPD) trial results

Completed

Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT00558285

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigator Site Adelaide, Australia
  • Novartis Investigator Site Clayton, Australia
  • Novartis Investigator Site Daw Park, Australia
  • Novartis Investigator site Heidelberg, Australia
View all 40 locations
View Trial Details
Completed

Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

NCT01646424

Conditions
Behavior, Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), +10 more
Locations
  • Research Site Adana, Turkey (Türkiye)
  • Research Site Afyonkarahisar, Turkey (Türkiye)
  • Research Site Ankara, Turkey (Türkiye)
  • Research Site Aydin, Turkey (Türkiye)
View all 20 locations
View Trial Details
Completed

Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®

NCT00542880

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Research Site Monte Grande, Buenos Aires, Argentina
  • Research Site Quilmes, Buenos Aires, Argentina
  • Research Site San Miguel de Tucumán, Tucumán Province, Argentina
  • Research Site Ciudad Autonoma de Bs. As., Argentina
View all 59 locations
View Trial Details
Completed

Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01054170

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +15 more
Locations
  • Research Site Kingston, Ontario, Canada
  • Research Site Québec, Quebec, Canada
  • Research Site Hellerup, Denmark
  • Research Site Hvidovre, Denmark
View Trial Details

Related conditions